Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Clinical Trials.gov
13 Jan, 2020 ,

Mitsubishi Tanabe Pharma Corporation is conducting an Interventional study in 300 participants in order to evaluate the efficacy and safety of Canagliflozin (TA-7284) in Japanese patients with Diabetic Nephropathy, compared with placebo.  

Source